David W Gryska - Net Worth and Insider Trading

David W Gryska Net Worth

The estimated net worth of David W Gryska is at least $10 Million dollars as of 2024-12-29. David W Gryska is the Director of Seagen Inc and owns about 40,253 shares of Seagen Inc (SGEN) stock worth over $9 Million. David W Gryska is the Executive Vice President, CFO of Incyte Corp and owns about 10,970 shares of Incyte Corp (INCY) stock worth over $759,453. David W Gryska is also the CFO of Celgene Corp and owns about 3,228 shares of Celgene Corp (CELG) stock worth over $349,399. Besides these, David W Gryska also holds Mind Medicine Inc (MNMD) , PDL BioPharma Inc (PDLI) . Details can be seen in David W Gryska's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David W Gryska has not made any transactions after 2024-12-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of David W Gryska

To

David W Gryska Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David W Gryska owns 9 companies in total, including GW Pharmaceuticals PLC (GWPH) , PDL BioPharma Inc (PDLI) , and Aerie Pharmaceuticals Inc (AERI) among others .

Click here to see the complete history of David W Gryska’s form 4 insider trades.

Insider Ownership Summary of David W Gryska

Ticker Comapny Transaction Date Type of Owner
GWPH GW Pharmaceuticals PLC 2020-09-14 director
PDLI PDL BioPharma Inc 2020-12-30 director
AERI Aerie Pharmaceuticals Inc 2013-10-25 director
LIMIT LIMIT 2022-11-11 director
LIMIT LIMIT 2018-02-21 Executive Vice President & CFO
LIMIT LIMIT 2014-02-06 director
LIMIT LIMIT 2012-05-11 director & Chief Operating Officer
LIMIT LIMIT 2023-01-10 director
LIMIT LIMIT 2024-12-05 director

David W Gryska Latest Holdings Summary

David W Gryska currently owns a total of 5 stocks. Among these stocks, David W Gryska owns 40,253 shares of Seagen Inc (SGEN) as of November 11, 2022, with a value of $9 Million and a weighting of 88.06%. David W Gryska owns 10,970 shares of Incyte Corp (INCY) as of February 21, 2018, with a value of $759,453 and a weighting of 7.26%. David W Gryska also owns 3,228 shares of Celgene Corp (CELG) as of May 4, 2010, with a value of $349,399 and a weighting of 3.34%. The other 2 stocks Mind Medicine Inc (MNMD) , PDL BioPharma Inc (PDLI) have a combined weighting of 1.33% among all his current holdings.

Latest Holdings of David W Gryska

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SGEN Seagen Inc 2022-11-11 40,253 228.74 9,207,471
INCY Incyte Corp 2018-02-21 10,970 69.23 759,453
CELG Celgene Corp 2010-05-04 3,228 108.24 349,399
MNMD Mind Medicine Inc 2024-12-05 19,851 6.84 135,781
PDLI PDL BioPharma Inc 2020-12-30 1,387 2.47 3,426

Holding Weightings of David W Gryska


David W Gryska Form 4 Trading Tracker

According to the SEC Form 4 filings, David W Gryska has made a total of 6 transactions in Seagen Inc (SGEN) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Seagen Inc is the sale of 7,500 shares on November 11, 2022, which brought David W Gryska around $968,250.

According to the SEC Form 4 filings, David W Gryska has made a total of 0 transactions in Incyte Corp (INCY) over the past 5 years. The most-recent trade in Incyte Corp is the sale of 1,952 shares on February 21, 2018, which brought David W Gryska around $167,013.

According to the SEC Form 4 filings, David W Gryska has made a total of 0 transactions in Celgene Corp (CELG) over the past 5 years. The most-recent trade in Celgene Corp is the sale of 76,186 shares on May 4, 2010, which brought David W Gryska around $2 Million.

More details on David W Gryska's insider transactions can be found in the Insider Trading History of David W Gryska table.

Insider Trading History of David W Gryska

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David W Gryska Trading Performance

GuruFocus tracks the stock performance after each of David W Gryska's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David W Gryska is 25.58%. GuruFocus also compares David W Gryska's trading performance to market benchmark return within the same time period. The performance of stocks bought by David W Gryska within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how David W Gryska's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of David W Gryska

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -3.15 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -3.03 LIMIT LIMIT LIMIT LIMIT LIMIT

David W Gryska Ownership Network

Ownership Network List of David W Gryska

No Data

Ownership Network Relation of David W Gryska

Insider Network Chart

David W Gryska Owned Company Details

What does GW Pharmaceuticals PLC do?

Who are the key executives at GW Pharmaceuticals PLC?

David W Gryska is the director of GW Pharmaceuticals PLC. Other key executives at GW Pharmaceuticals PLC include Chief Legal Officer Douglas B. Snyder , Chief Medical Officer Volker Knappertz , and Secretary Adam D. George .

GW Pharmaceuticals PLC (GWPH) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of GW Pharmaceuticals PLC (GWPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of GW Pharmaceuticals PLC (GWPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

GW Pharmaceuticals PLC (GWPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

GW Pharmaceuticals PLC Insider Transactions

No Available Data

David W Gryska Mailing Address

Above is the net worth, insider trading, and ownership report for David W Gryska. You might contact David W Gryska via mailing address: 749 N Mary Ave, Sunnyvale Ca 94085.

Discussions on David W Gryska

No discussions yet.